ArticleMolecular oncology2021

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Anna Barkovskaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.